ClinicalTrials.gov
public full text
Public Domain
SGLT2 Inhibitors and Reducing the Risk of Cancers Among Diabetics , an Observational Study
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
ClinicalTrials.gov Show glossary Search for terms Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Related documents
- Association of SGLT2 inhibitors use with a lower risk of biliary diseases in patients with type 2 diabetes mellitus: a retrospective cohort study#5153
- SGLT2 Inhibitors in Cardio-Oncology: A Systematic Review and Meta-Analysis#292585
- Safety and efficacy of sglt2 inhibitors: A multiple-treatment meta-analysis of clinical decision indicators#935601
- SGLT2 Inhibitors in Type 2 Diabetes Mellitus: A Comparative Review of Efficacy, Cardiovascular and Renal Benefits, and Cost#179740
- Efficacy and Safety Comparison of Cofrogliptin Add-on Versus Metformin Dose-escalation in Type 2 Diabetes Patients Inadequately Controlled With SGLT-2 Inhibitors Plus Low-Dose Metformin:A Multicenter, Open-Label Trial#303695
Record · ID 353427 · SHA-256 66ba04e716eacfbd
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive